CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications

: Lip, Gregory Y.H.; Teppo, Konsta; Nielsen, Peter Brönnum

Publisher: Oxford University Press

: 2024

: European Heart Journal

: ehae540

: 45

: 36

: 3718

: 3720

: 0195-668X

: 1522-9645

DOI: https://doi.org/10.1093/eurheartj/ehae540

: https://doi.org/10.1093/eurheartj/ehae540

: 
K.T. Research Grants: The Finnish Foundation for Cardiovascular Research, Aarne and Aili Turunen Foundation. P.B.N. Consultant fees from Boehringer Ingelheim, grants and consultant fees from Daiichi-Sankoy, grants from BMS/Pfizer, and grants and consultant fees from Bayer outside the submitted work. G.Y.H.L. Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 899871.